timolol has been researched along with Disease Exacerbation in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 16 (51.61) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Karkhur, S; Sharma, B; Soni, D | 1 |
| Chen, YW; Hsu, CW; Huang, KY; Lin, CH; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC | 1 |
| Erdinest, N; Morad, Y | 1 |
| Holló, G; Hommer, A; Schmidl, D | 1 |
| Kawasaki, R; Maekawa, S; Nakazawa, T; Omodaka, K; Takahashi, H; Tsuda, S; Yokoyama, Y | 1 |
| Lindsley, K; Sena, DF | 2 |
| Martínez, A; Sánchez, M | 1 |
| Määttä, M; Puska, P | 1 |
| Martínez, A; Sanchez-Salorio, M | 1 |
| Dariel, R; Fénolland, JR; Giraud, JM; Hamam, O; Maÿ, F; Renard, JP; Sadat, AM | 1 |
| Harris, A; Januleviciene, I; Shoshani, Y; Siesky, B | 1 |
| Häfliger, IO; Pajic, B; Pajic-Eggspuehler, B | 1 |
| Araie, M; Kitazawa, Y; Ohashi, Y; Shirato, S; Yamazaki, Y | 1 |
| Sihota, R | 1 |
| Hendrikse, F; Peeters, A; Prins, MH; Schouten, JS; Webers, CA | 1 |
| Babić, N; Camara, C; Cieślińska, I; Ferkova, S; Holló, G; Januleviciene, I; Kaluzny, BJ; Kóthy, P; Kozobolis, V; Kristoffersen, MS; Krzyzanowska-Berkowska, P; Mikropoulos, DG; Misiuk-Hojlo, M; Nelson, LA; Quaranta, L; Russo, A; Stewart, JA; Stewart, WC; Teus, MA; Thelen, U | 1 |
| Beckers, HJ; Hendrikse, F; Jansonius, NM; Schouten, JS; Severens, JL; van Gestel, A; Webers, CA | 1 |
| Araie, M; Kitazawa, Y; Matsumoto, C; Ohashi, Y; Shirato, S; Yamazaki, Y | 1 |
| De Moraes, CG; Gardiner, SK; Greenfield, DS; Krupin, T; Liebmann, JM; Ritch, R | 1 |
| Au Eong, KG; Gazzard, G; Saw, SM; Tan, DT | 1 |
| Nummelin, K; Vainio-Jylhä, E; Vuori, ML | 1 |
| Covert, DW; Halpern, MT; Robin, AL | 1 |
| Brown, B; Chen, JC; Edwards, MH; Lew, JK; Schmid, KL; Yu, BS | 1 |
| Aung, T; Chan, YH; Chew, PT; Ho, CL; Khoo, BK; Liu, YP; Oen, FT; Seah, SK; See, J; Thean, LH; Viswanathan, AC; Wong, HT | 1 |
| Greenfield, DS; Krupin, T; Liebmann, JM; Ritch, R; Rosenberg, LF; Yang, JW | 1 |
| Werner, E | 1 |
| Werner, EB | 1 |
| Burnstein, Y; Robin, AL | 1 |
| Anielska, E; Czechowicz-Janicka, K; Dyczkowska, A; Orlewska, E; Tobota, Z | 1 |
| Koh, A; Saw, SM; Shih-Yen, EC; Tan, D | 1 |
8 review(s) available for timolol and Disease Exacerbation
| Article | Year |
|---|---|
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Celiprolol; Disease Progression; Female; Humans; Incidence; Infusions, Intravenous; Male; Practolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Sotalol; Status Asthmaticus; Timolol | 2021 |
[TREATMENTS FOR SLOWING THE PROGRESSION OF MYOPIA].
Topics: Atropine; Contact Lenses, Hydrophilic; Disease Progression; Eyeglasses; Humans; Myopia; Timolol | 2017 |
Neuroprotection for treatment of glaucoma in adults.
Topics: Adult; Antihypertensive Agents; Brimonidine Tartrate; Disease Progression; Glaucoma, Open-Angle; Humans; Neuroprotective Agents; Optic Nerve; Optic Nerve Diseases; Quinoxalines; Randomized Controlled Trials as Topic; Retinal Ganglion Cells; Timolol | 2013 |
Neuroprotection for treatment of glaucoma in adults.
Topics: Adult; Antihypertensive Agents; Brimonidine Tartrate; Disease Progression; Glaucoma, Open-Angle; Humans; Neuroprotective Agents; Optic Nerve; Optic Nerve Diseases; Randomized Controlled Trials as Topic; Retinal Ganglion Cells; Timolol | 2017 |
[Drug therapy for glaucoma].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Muscarinic Antagonists; Pilocarpine; Timolol | 2009 |
An Indian perspective on primary angle closure and glaucoma.
Topics: Acute Disease; Anterior Chamber; Antihypertensive Agents; Chronic Disease; Cornea; Disease Progression; Drug Administration Schedule; Glaucoma, Angle-Closure; Humans; Incidence; India; Iris; Latanoprost; Ocular Hypertension; Ophthalmologic Surgical Procedures; Prevalence; Prostaglandins F, Synthetic; Timolol | 2011 |
Myopia: attempts to arrest progression.
Topics: Accommodation, Ocular; Adolescent; Adult; Atropine; Biofeedback, Psychology; Child; Contact Lenses; Disease Progression; Eye Movements; Eyeglasses; Humans; Intraocular Pressure; Medicine, Chinese Traditional; Myopia; Ophthalmic Solutions; Pirenzepine; Timolol; Tropicamide | 2002 |
Interventions to retard myopia progression in children: an evidence-based update.
Topics: Atropine; Child; Child, Preschool; Contact Lenses, Hydrophilic; Databases, Factual; Disease Progression; Evidence-Based Medicine; Eyeglasses; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Timolol; Tropicamide | 2002 |
12 trial(s) available for timolol and Disease Exacerbation
| Article | Year |
|---|---|
Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Disease Progression; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Timolol; Tonometry, Ocular; Vision Disorders; Visual Field Tests; Visual Fields | 2019 |
Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Topics: Aged; Antihypertensive Agents; Disease Progression; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Orbit; Prospective Studies; Regional Blood Flow; Sulfonamides; Thiophenes; Time Factors; Timolol; Treatment Outcome; Visual Fields | 2008 |
Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.
Topics: Aged; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Carbonic Anhydrase Inhibitors; Ciliary Arteries; Disease Progression; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Artery; Proportional Hazards Models; Prospective Studies; Retinal Artery; Risk Factors; Sulfonamides; Thiazines; Thiophenes; Timolol; Tonometry, Ocular; Ultrasonography, Doppler, Color; Vision Disorders; Visual Fields | 2010 |
Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Disease Progression; Dosage Forms; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome; Visual Fields | 2010 |
Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.
Topics: Administration, Topical; Adult; Antihypertensive Agents; Disease Progression; Double-Blind Method; Female; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Timolol; Treatment Outcome; Vision Disorders; Visual Field Tests; Visual Fields | 2010 |
Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy.
Topics: Adrenergic beta-Antagonists; Disease Progression; Double-Blind Method; Female; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Myopia; Ophthalmic Solutions; Prognosis; Propanolamines; Prospective Studies; Risk Factors; Timolol; Tonometry, Ocular; Vision Disorders; Visual Fields | 2012 |
Risk factors for visual field progression in the low-pressure glaucoma treatment study.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Aged; Brimonidine Tartrate; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Gonioscopy; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Risk Factors; Timolol; Vision Disorders; Visual Acuity; Visual Field Tests; Visual Fields | 2012 |
Progression of retinal nerve fibre layer damage in betaxolol- and timolol-treated glaucoma patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Disease Progression; Double-Blind Method; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Photography; Prospective Studies; Retinal Ganglion Cells; Timolol | 2002 |
Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.
Topics: Aged; Antihypertensive Agents; Black People; Cloprostenol; Disease Progression; Double-Blind Method; Drug Costs; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Travoprost; United States; Vision Disorders; Visual Fields | 2002 |
Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure.
Topics: Acute Disease; Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Disease Progression; Female; Glaucoma, Angle-Closure; Humans; Linear Models; Male; Middle Aged; Prospective Studies; Quinoxalines; Timolol; Visual Field Tests; Visual Fields | 2004 |
The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Disease Progression; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Quinoxalines; Research Design; Timolol; Visual Field Tests; Visual Fields | 2005 |
Pressure or progression?
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Timolol; Visual Fields | 1999 |
11 other study(ies) available for timolol and Disease Exacerbation
| Article | Year |
|---|---|
Necrotising fungal scleritis with full-thickness scleral melt and circumferential progression: a novel debridement approach.
Topics: Adrenal Cortex Hormones; Adult; Agaricales; Antifungal Agents; Diagnosis, Differential; Disease Progression; Eye Infections, Fungal; Eye Pain; Female; Humans; Scleritis; Sulfonamides; Thiophenes; Timolol | 2020 |
Referral for first glaucoma surgery in Europe, the ReF-GS study.
Topics: Adrenergic beta-Antagonists; Aged; Carbonic Anhydrase Inhibitors; Disease Progression; European Union; Exfoliation Syndrome; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Referral and Consultation; Surveys and Questionnaires; Timolol; Trabeculectomy | 2019 |
[Atypical unilateral glaucoma in a young patient].
Topics: Adolescent; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Filtering Surgery; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Optic Disk; Prostaglandins F, Synthetic; Timolol; Tomography, Optical Coherence; Visual Fields | 2010 |
Predictors for visual field progression.
Topics: Antihypertensive Agents; Blood Flow Velocity; Disease Progression; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Optic Disk; Regional Blood Flow; Sulfonamides; Thiazines; Thiophenes; Timolol; Vision Disorders; Visual Fields | 2010 |
The clinical impact of 2 different strategies for initiating therapy in patients with ocular hypertension.
Topics: Adult; Antihypertensive Agents; Blindness; Brimonidine Tartrate; Decision Trees; Disease Progression; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Markov Chains; Middle Aged; Models, Biological; Monte Carlo Method; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Risk Assessment; Sulfonamides; Thiophenes; Timolol | 2011 |
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Disease Progression; Drug Costs; Europe; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Time Factors; Timolol; Travoprost; Treatment Outcome | 2011 |
The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
Topics: Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Cost-Benefit Analysis; Decision Support Techniques; Disease Progression; Drug Costs; Economics, Pharmaceutical; Follow-Up Studies; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quality-Adjusted Life Years; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2012 |
AC/A ratios in myopic and emmetropic Hong Kong children and the effect of timolol.
Topics: Accommodation, Ocular; Adrenergic beta-Antagonists; Case-Control Studies; Child; Convergence, Ocular; Disease Progression; Esotropia; Exotropia; Eyeglasses; Hong Kong; Humans; Myopia; Timolol | 2003 |
Progressive normal-tension glaucoma. I. Analysis.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Aged; Disease Progression; Epinephrine; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Timolol; Trabeculectomy; Visual Fields | 1996 |
Treatment of progressive normal-tension glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Disease Progression; Epinephrine; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Ophthalmic Solutions; Timolol; Trabeculectomy; Visual Acuity; Visual Fields | 1997 |
[Analysis of glaucoma therapy costs in Poland. I--population of the Mazovian District].
Topics: Adult; Aged; Aged, 80 and over; Costs and Cost Analysis; Disease Progression; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Office Visits; Pilocarpine; Poland; Sulfonamides; Thiophenes; Timolol | 2000 |